Common polymorphisms in the interleukin-6 gene and myocardial infarction risk: A meta-analysis

Genetic Testing and Molecular Biomarkers

Volumn 18, Issue 5, 2014, Pages 330-340

  Jin, Yuanzhe ^a   Wang, Qi ^a   Wang, Guofeng ^a   Zhang, Xueying ^a   Yan, Bin ^a   Hu, Weina ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; BIOLOGICAL MARKER;

ALLELE; ARTICLE; CARDIOVASCULAR RISK; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HARDY WEINBERG DISTRIBUTION LAW; HEART INFARCTION; HUMAN; INTERLEUKIN 6 GENE; MATHEMATICAL MODEL; META ANALYSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEWCASTLE OTTAWA SCALE; POLYMERASE CHAIN REACTION; PUBLISHING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; GENETIC PREDISPOSITION; GENETICS; METABOLISM;

BIOLOGICAL MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC;

EID: 84899802578     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2013.0404     Document Type: Article

References (38)

1. Abarbanell AM, Herrmann JL, Weil BR, et al. (2010) Animal models of myocardial and vascular injury. J Surg Res 162: 239-249
2. Anker SD, von Haehling S (2004) Inflammatory mediators in chronic heart failure: an overview. Heart 90:464-470
3. Banks WA, Kastin AJ (1991) Blood to brain transport of interleukin links the immune and central nervous systems. Life Sci 48:PL117-PL121
4. Bennermo M, Nordin M, Lundman P, et al. (2011) Genetic and environmental influences on the plasma interleukin-6 concentration in patients with a recent myocardial infarction: a case-control study. J Interferon Cytokine Res 31:259-264
5. Brocker C, Thompson D, Matsumoto A, et al. (2010) Evolutionary divergence and functions of the human interleukin (IL) gene family. Hum Genomics 5:30-55
6. Chiappelli M, Tampieri C, Tumini E, et al. (2005) Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet 32:349-353
7. Coker A, Arman A, Soylu O, et al. (2011) Lack of association between IL-1 and IL-6 gene polymorphisms and myocardial infarction in Turkish population. Int J Immunogenet 38:201-208
8. de Gaetano M, Quacquaruccio G, Di Castelnuovo A, et al. (2011) Haplotypes and haplotype-pairs of IL-1 beta and IL-6 genes and risk of non fatal myocardial infarction in the Western New York Acute MI Study. Thromb Haemost 106:1231-1233
9. Dupont WD, Plummer WD, Jr. (1990) Power and sample size calculations. A review and computer program. Control Clin Trials 11:116-128
10. Fu HX, Zhang JY, Li GS, et al. (2006) The serum level of Interleukin-6 and its gene polymorphism in patients with acute myocardial infarction. J Clin Interm Med 23:542-544
11. Georges JL, Loukaci V, Poirier O, et al. (2001) Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Temoin de l'Infarctus du Myocarde. J Mol Med (Berl) 79:300-305
12. Hansson GK, Hermansson A (2011) The immune system in atherosclerosis. Nat Immunol 12:204-212
13. Iacoviello L, Di Castelnuovo A, Gattone M, et al. (2005) Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol 25:222-227
14. Ioannidis JP, Patsopoulos NA, Rothstein HR (2008) Reasons or excuses for avoiding meta-analysis in forest plots. BMJ 336:1413-1415
15. Jackson D, White IR, Riley RD (2012) Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med 31:3805-3820
16. Kelberman D, Hawe E, Luong LA, et al. (2004) Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study. Thromb Haemost 92: 1122-1128
17. Licastro F, Chiappelli M, Caldarera CM, et al. (2004) The concomitant presence of polymorphic alleles of interleukin-1beta, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men. Results from a pilot study. Mech Ageing Dev 125:575-579
18. Lieb W, Pavlik R, Erdmann J, et al. (2004) No association of interleukin-6 gene polymorphism (-174 G/C) with myocardial infarction or traditional cardiovascular risk factors. Int J Cardiol 97:205-212
19. Lytvyn OI, Kopitsa MP, Petyunina OV (2004) Interaction between inflammation and thrombosis in acute coronary syndrome. Kardiol Pol 61:110-116; discussion 114-116
20. Mulle JG, Vaccarino V (2013) Cardiovascular disease, psychosocial factors, and genetics: the case of depression. Prog Cardiovasc Dis 55:557-562
21. Nauck M, Winkelmann BR, Hoffmann MM, et al. (2002) The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J Mol Med (Berl) 80:507-513
22. Neri M, Fineschi V, Di Paolo M, et al. (2013) Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction. Curr Vasc Pharmacol April 29 [Epub ahead of print]; PMID: 23628007
23. Papanicolaou DA, Wilder RL, Manolagas SC, et al. (1998) The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128:127-137
24. Park S, Youn JC, Shin DJ, et al. (2007) Genetic polymorphism in the pregnancy-associated plasma protein-A associated with acute myocardial infarction. Coron Artery Dis 18:417-422
25. Peters JL, Sutton AJ, Jones DR, et al. (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA 295:676-680
26. Pierre-Paul D, Gahtan V (2003) Noncholesterol-lowering effects of statins. Vasc Endovasc Surg 37:301-313
27. Ridker PM, Pare G, Parker AN, et al. (2009) Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: genomewide analysis among 18 245 initially healthy women from the Women's Genome Health Study. Circ Cardiovasc Genet 2:26-33
28. Sims JE, Smith DE (2010) The IL-1 family: regulators of immunity. Nat Rev Immunol 10:89-102
29. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603-605
30. Stroup DF, Berlin JA, Morton SC, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008-2012
31. Teixeira R, Goncalves L, Gersh B (2013) Acute myocardial infarction-historical notes. Int J Cardiol 167:1825-1834
32. Topol EJ, Smith J, Plow EF, et al. (2006) Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet 15 Spec No 2:R117-R123
33. Tousoulis D, Antoniades C, Bosinakou E, et al. (2007) Differences in inflammatory and thrombotic markers between unstable angina and acute myocardial infarction. Int J Cardiol 115:203-207
34. Turpie AG, Esmon C (2011) Venous and arterial thrombosis- pathogenesis and the rationale for anticoagulation. Thromb Haemost 105:586-596
35. Vakili H, Ghaderian SM, Akbarzadeh Najar R, et al. (2011) Genetic polymorphism of interleukin-6 gene and susceptibility to acute myocardial infarction. Coron Artery Dis 22:299-305
36. Winckers K, ten Cate H, Hackeng TM (2013) The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis. Blood Rev 27:119-132
37. Zee RY, Hennessey H, Michaud SE, et al. (2008) Genetic variants within the interleukin-1 gene cluster, and risk of incident myocardial infarction, and ischemic stroke: a nested case-control approach. Atherosclerosis 201:124-129
38. Zintzaras E, Ioannidis JP (2005) HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 21:3672-3673.